Original ResearchPublished 18 September 2026A novel minimally humanized mouse model of aniridia for preclinical evaluation of CRISPR gene editing strategiesSeyedeh Zeinab Mirjalili Mohanna · Andrea J. Korecki · Pardis Kazemian · Tess C. Lengyell · Bethany A. Adair · Blair R. Leavitt · Elizabeth M. SimpsonFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1910209
ReviewPublished 17 September 2026CRISPR/Cas9 in soybean research: a measured leap toward genetic refinementSmrutirekha Sahu · Pandian Rajendran · Sanket Arunrao Ghumde · Diksha Prakash · Shikha Dixit · Deepak Pawar · Dharavath Nagaraju · Vinutha T · Sandeep B. Adavi · Palaiyur Nanjappan Sivalingam · Ashish Marathe · Pramod Kumar RaiFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1821910
ReviewPublished 10 September 2026Clinical translation of CRISPR-Cas9 therapeutics in cancer and inherited genetic disordersKhushi Bashir · Prathiksha Vasudev · Vikas Chhetri · Devika Prasad Dubhashi · Yash Gurunath Teli · Rhitam Biswas · Sudha Ramaiah · Anand AnbarasuFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1868779
ReviewPublished 15 April 2026Advances in gene editing for legume improvement: technologies, progress, and prospectsShallu Thakur · Shalini Pareek · G. P. Dixit · Geoffrey Meru · Alok DasFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1789952
Systematic ReviewPublished 3 December 2025CRISPR–Cas9 mediated gene therapy in inherited bone marrow failure syndromesNadeesha J. S. Munugoda Hewa · Rajendra KC · Alex W. Hewitt · Kirsten A. FairfaxFrontiers in Hematologydoi 10.3389/frhem.2025.1713610
